IL-6 affects the health prognosis by changing metabolic activity, hematopoiesis, and nutritional requirements and also producing significant endothelium injury, as seen in ovarian cancer (Coward et al., 2011; Macciò and Madeddu, 2012). This evidence concerns the gene IL6 and ovarian carcinoma.